Compared to FMT from HCs, FMT from RA patients increased the percentage of T-lymphocyte (CD3e+ CD4+) in PPs and spleen, indicating a set of immune activation (Fig. 4A). This evidence concerns the gene CD3E and rheumatoid arthritis.